San Diego, CA, United States of America

Darin Hildebrandt

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Revagenix, Inc.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darin Hildebrandt. Retrieved from https://idiyas.com/inventor/darin-hildebrandt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Darin Hildebrandt

Introduction

Darin Hildebrandt, an accomplished inventor based in San Diego, California, has made significant contributions to the field of antibacterial research. With a total of two patents to his name, Hildebrandt's work focuses on innovative methods for synthesizing aminoglycosides, which are crucial in combatting bacterial infections.

Latest Patents

Hildebrandt's latest patents revolve around the "Modular synthesis of aminoglycosides." The present disclosure details novel methods for preparing antibacterial aminoglycoside compounds, as well as the compounds used in such preparations. This research plays a vital role in advancing therapeutic options for treating bacterial infections.

Career Highlights

Darin Hildebrandt is currently a key member of Revagenix, Inc., a company dedicated to developing cutting-edge therapeutic solutions. His expertise and innovative approach have positioned him as an influential figure in his field within the organization.

Collaborations

Throughout his career, Hildebrandt has collaborated with notable colleagues, including Andrew Calabrese and Timothy Robert Kane. These partnerships enhance the collaborative spirit of innovation at Revagenix, Inc., driving forward the company's mission to develop effective antibacterial treatments.

Conclusion

Darin Hildebrandt's dedication to scientific advancement through his innovative patents and collaborative efforts underscores the importance of research in the field of antibacterial compounds. His work at Revagenix, Inc. exemplifies how individual inventors can impact healthcare and contribute to the fight against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…